SOLUtion Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 8


  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $300K

  • Investors
  • 3

SOLUtion General Information


Developer of a medical device intended to help patients with congenital adrenal hyperplasia, addison's disease and idiopathic adrenal insufficiency. The company's product offers its users an autoinjector which provides reliable life-saving care and reclaimed confidence in times of adrenal crises, enabling them to get relief from life-threatening medical emergency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Corporate Office
  • Philadelphia, PA
  • United States
+1 (484) 000-0000

SOLUtion Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SOLUtion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 20-Apr-2023 $300K 00.000 Completed Generating Revenue
3. Debt - General 03-Sep-2021 00000 00000 Completed Generating Revenue
2. Accelerator/Incubator 16-Jul-2020 $25K Completed Generating Revenue
1. Accelerator/Incubator 21-May-2019 $25K $25K Completed Generating Revenue
To view SOLUtion’s complete valuation and funding history, request access »

SOLUtion Executive Team (4)

Name Title Board Seat Contact Info
Julia Anthony Co-Founder, Chief Strategy Officer & President
Todd Wallach Chief Executive Officer & Board Member
You’re viewing 2 of 4 executive team members. Get the full list »

SOLUtion Board Members (1)

Name Representing Role Since
Todd Wallach SOLUtion Chief Executive Officer & Board Member 000 0000
To view SOLUtion’s complete board members history, request access »

SOLUtion Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SOLUtion Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ben Franklin Technology Partners of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
Penn Center for Innovation Accelerator/Incubator 000 0000 000000 0
Nextfab Accelerator/Incubator Minority 000 0000 000000 0
To view SOLUtion’s complete investors history, request access »


  • When was SOLUtion founded?

    SOLUtion was founded in 2019.

  • Who is the founder of SOLUtion?

    Julia Anthony, Jonathan Kiel, and Arden Gewirtz are the founders of SOLUtion.

  • Who is the CEO of SOLUtion?

    Julia Anthony and Todd Wallach are the CEOs of SOLUtion.

  • Where is SOLUtion headquartered?

    SOLUtion is headquartered in Philadelphia, PA.

  • What is the size of SOLUtion?

    SOLUtion has 8 total employees.

  • What industry is SOLUtion in?

    SOLUtion’s primary industry is Drug Delivery.

  • Is SOLUtion a private or public company?

    SOLUtion is a Private company.

  • What is SOLUtion’s current revenue?

    The current revenue for SOLUtion is 00000.

  • How much funding has SOLUtion raised over time?

    SOLUtion has raised $1.27M.

  • Who are SOLUtion’s investors?

    Ben Franklin Technology Partners of Southeastern Pennsylvania, Penn Center for Innovation, and Nextfab have invested in SOLUtion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »